SCPH icon

scPharmaceuticals

38 hedge funds and large institutions have $39.8M invested in scPharmaceuticals in 2022 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 16 increasing their positions, 10 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
38
Holders Change
+1
Holders Change %
+2.7%
% of All Funds
0.64%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
4
Increased
16
Reduced
10
Closed
3
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Shares
Change %
VF
26
Virtu Financial
New York
$53K +$53K +10,999 New
SCA
27
Sandy Cove Advisors
Massachusetts
$51K
TRCT
28
Tower Research Capital (TRC)
New York
$31K +$30.5K +6,396 +6,396%
O
29
OrbiMed
New York
$23.1K
AC
30
Armistice Capital
New York
$13K +$13K +2,700,000 New
Osaic Holdings
31
Osaic Holdings
Arizona
$13K -$4.76K -974 -27%
UBS Group
32
UBS Group
Switzerland
$10K +$5.35K +1,152 +115%
Royal Bank of Canada
33
Royal Bank of Canada
Ontario, Canada
$10K +$9.73K +2,000 +3,571%
Group One Trading
34
Group One Trading
Illinois
$6K +$3.03K +668 +102%
Bank of America
35
Bank of America
North Carolina
$5K -$195 -39 -4%
Fidelity Investments
36
Fidelity Investments
Massachusetts
$3K -$730 -174 -20%
BNP Paribas Financial Markets
37
BNP Paribas Financial Markets
France
$511
RCM
38
RA Capital Management
Massachusetts
-$15.1M -2,658,583 Closed
JGC
39
J. Goldman & Co
New York
-$383K -67,500 Closed
Envestnet Asset Management
40
Envestnet Asset Management
Illinois
-$58K -10,228 Closed